Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1987-1-20
pubmed:databankReference
pubmed:abstractText
In the DNAs of all Ph1-positive chronic myelocytic leukemia patients studied to date, a breakpoint on chromosome 22 (the Ph1 chromosome) can be demonstrated with a probe from the bcr (breakpoint cluster region). Although the K562 cell line was established from cells of a chronic myelocytic leukemia patient, we have been unable to detect the Ph1 chromosome by cytogenetic means. Employing a probe from the 5' region of bcr, we have cloned an amplified Ph1 breakpoint fragment from K562. This demonstrates that K562 contains multiple remnants of a Ph1 chromosome with a breakpoint within bcr and thus may serve as a model system for the study of Ph1-positive chronic myelocytic leukemia at a molecular level. The isolation of bcr cDNA sequences shows that parts of bcr encode a protein. Employing K562, we demonstrate the presence of an abnormally sized mRNA species hybridizing to c-abl and to a bcr cDNA probe, indicating the possible consequence of the Ph1 translocation on a transcriptional level in chronic myelocytic leukemia. The isolation and sequencing of a cDNA containing the breakpoint area of this mRNA provide further evidence for its chimeric structure. Cloning of large stretches of chromosomal DNA flanking bcr and c-abl sequences in K562 and identification of the exons participating in the formation of the chimeric mRNA shows that a splice of at least 99 kilobases is made to fuse the 3' bcr exon to the 5' c-abl exon. Furthermore two chimeric cDNAs were isolated containing chromosome 9 sequences that map 43.5 kilobases downstream from the K562 breakpoint. These chromosome 9 sequences neither hybridize to the 8.5-kilobase chimeric c-abl mRNA nor to normal c-abl mRNAs in Hela cells and probably represent incorrect splicing products present in the K562 cell line.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-1195397, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-163658, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-2989692, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-2989703, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-3864009, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-4039028, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-4126434, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6091052, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6091099, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6142307, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6159595, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6193890, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6198242, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6204766, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6246368, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6260957, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6266915, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6281890, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6299580, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6300662, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6302194, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6306134, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6308652, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6312838, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6316147, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6319012, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6319018, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6580644, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6587568, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6772444, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6791577, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-699045, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-6996765, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-7121606, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023859-912752
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0270-7306
pubmed:author
pubmed:issnType
Print
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
607-16
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1986
pubmed:articleTitle
The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr/c-abl transcript.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't